Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
7
Bearish filings
104
Named actors
12
Disclosed $ (bull / bear)
$82.3M + 2 of unknown size / $745.1M + 5 of unknown size
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-08-07 | Director Fairmount Healthcare Fund II L.P. | exercised options & held the shares | $1.9M | SEC ↗ |
| 2026-08-07 | Director Harwin Peter Evan | exercised options & held the shares | $1.9M | SEC ↗ |
| 2026-08-07 | Director Fairmount Funds Management LLC | exercised options & held the shares | $1.9M | SEC ↗ |
| 2026-08-07 | Director Kiselak Tomas | exercised options & held the shares | $1.9M | SEC ↗ |
| 2026-08-05 | Chief Medical Officer Dambkowski Carl | sold | $738K | SEC ↗ |
86 more disclosures in the window — the full record, scoring, and track-record evidence are for members.
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-07-24 | Chief Financial Officer Henderson Jane | gifted | — | SEC ↗ |
| 2026-07-14 | Chief Medical Officer Dambkowski Carl | gifted | — | SEC ↗ |
| 2026-07-10 | Chief Executive Officer HENDERSON MICHAEL THOMAS | gifted | — | SEC ↗ |
| 2026-07-08 | Chief Executive Officer HENDERSON MICHAEL THOMAS | sold | $2.7M | SEC ↗ |
| 2026-07-01 | Chief Medical Officer Dambkowski Carl | sold | $730K | SEC ↗ |
| 2026-07-01 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) CARL DAMBKOWSKI | filed notice to sell | $2.2M | SEC ↗ |
| 2026-06-30 | Institution (13F) SOROS FUND MANAGEMENT LLC | reported a new position | $74.9M | — |
| 2026-06-22 | Chief Executive Officer HENDERSON MICHAEL THOMAS | sold | $10.6M | SEC ↗ |
| 2026-06-22 | Chief Medical Officer Dambkowski Carl | sold | $3.5M | SEC ↗ |
| 2026-06-22 | Officer (via THE CHARLES SCHWAB CORPORATION) HENDERSON MICHAEL THOMAS | filed notice to sell | $10.6M | SEC ↗ |
| 2026-06-22 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) CARL DAMBKOWSKI | filed notice to sell | $1.4M | SEC ↗ |
| 2026-06-10 | Chief Executive Officer HENDERSON MICHAEL THOMAS | sold | $557K | SEC ↗ |
| 2026-06-10 | Chief Executive Officer HENDERSON MICHAEL THOMAS | sold | $634K | SEC ↗ |
| 2026-06-10 | Chief Executive Officer HENDERSON MICHAEL THOMAS | sold | $91K | SEC ↗ |
| 2026-06-10 | Chief Executive Officer HENDERSON MICHAEL THOMAS | sold | $134K | SEC ↗ |
| 2026-06-10 | Chief Executive Officer HENDERSON MICHAEL THOMAS | sold | $199K | SEC ↗ |
| 2026-06-10 | Chief Executive Officer HENDERSON MICHAEL THOMAS | sold | $53K | SEC ↗ |
| 2026-06-03 | Chief Medical Officer Dambkowski Carl | sold | $433K | SEC ↗ |
| 2026-05-13 | Chief Executive Officer HENDERSON MICHAEL THOMAS | sold | $1.5M | SEC ↗ |
| 2026-05-13 | Chief Executive Officer HENDERSON MICHAEL THOMAS | sold | $111K | SEC ↗ |